Opendata, web and dolomites

REBOOT SIGNED

First-in-class implants for bone regeneration surgery after a bone, ligament or tendon injury

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REBOOT project word cloud

Explore the words cloud of the REBOOT project. It provides you a very rough idea of what is the project "REBOOT" about.

healing    life    chronic    surgical    community    industrial    first    transition    market    manufacturing    bones    population    ligaments    30    ages    ligament    sales    million    2015    abnormal    msds    injury    weights    surgery    metallic    mixed    spiral    20    materials    billions    marketed    operation    orthopaedic    regeneration    create    break    launch    feasibility    validated    ceramic       synthetic    toward    turnover    action    leaving    follow    cruciate    musculoskeletal    patients    disorders    bioresorbable    international    perspectives    sme    class    reboot    patented    screw    native    functional    millions    noraker    msd    implants    revision    tendon    shows    imperfect    experiencing    knee    made    100    re    trauma    full    glass    poor    worldwide    fragile    inflammation    capablity    bone    2018    rate    revolutionary    biocomposite    regenerative    too    world    quality    people    15    pain    disruptive    suffering    bioactive    polymer    instrument    recreate    injuries    multiplied    structure    days    formula    outcomes    enter    bioabsorbable    adoption    develops   

Project "REBOOT" data sheet

The following table provides information about the project.

Coordinator
NORAKER 

Organization address
address: 11/13 AVENUE ALBERT EINSTEIN CENTRE SCIENTIFIQUE ET TECHNOLOGIQUE
city: VILLEURBANNE
postcode: 69100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙545˙000 €
 EC max contribution 2˙481˙500 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NORAKER FR (VILLEURBANNE) coordinator 2˙481˙500.00

Map

 Project objective

NORAKER develops first-in-class implants for regenerative orthopaedic surgery to offer full healing to patients suffering from a bone, ligament or tendon injury. With project REBOOT, NORAKER will create the market of bone regeneration surgery. Each year in Europe, 1,6 million people require orthopaedic surgery after a bone, ligament or tendon injury, with many more cases expected as population ages. The current implants (made of metallic or bioresorbable materials) show imperfect healing outcomes, leaving millions of patients with fragile bones and poor quality of life (with 30% of inflammation, 20% of revision surgery and millions suffering from chronic pain and musculoskeletal disorders, MSDs). It weights billions of follow-up costs on the community. Enter NORAKER’s biocomposite surgical implants, made of bioactive glass – a revolutionary ceramic – mixed with a synthetic polymer, both bioabsorbable. This technology shows disruptive regeneration action: it can recreate up to 100% of the native-like functional bone structure with no inflammation, no abnormal pain, no MSD and a very low re-operation rate (4%). Today this patented technology is adapted to knee cruciate ligaments regeneration (with a world-first biocomposite screw marketed in 2015). In a SME Instrument Phase 1 project (2018), NORAKER has validated the feasibility of a new biocomposite formula with broader perspectives of regeneration for tendon, ligament and bone injuries. The Phase 2 project will do the industrial scale-up of this biocomposite and launch the industrial production of the first range of implants for the bone trauma market. Their adoption will support the transition toward regenerative orthopaedic surgery and break the spiral of pain and MSDs, which too many patients are experiencing these days. With this disruptive offer, NORAKER will become a scale-up operating worldwide, with a large manufacturing capablity, international sales and turnover multiplied by 15 in five years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REBOOT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REBOOT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

SQP (2019)

Opening new markets for Single Quantum Photodetectors

Read More  

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More